1. Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug
   Junyi Ren et al, 2022, Biomedicine & Pharmacotherapy CrossRef
2. Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
   Norihiro Sakai et al, 2023, Pharmaceutics CrossRef
3. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
   Patricia Cámara-Sánchez et al, 2022, International Journal of Molecular Sciences CrossRef
4. Chemical mixture that targets the epidermal growth factor pathway impairs human trophoblast cell functions
   Anita A. Waye et al, 2024, Toxicology and Applied Pharmacology CrossRef
5. Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes
   Nirali Shukla et al, 2024, Life Sciences CrossRef
6. Primary assessment of medicines for expected migrastatic potential with holographic incoherent quantitative phase imaging
   Markéta Šuráňová et al, 2023, Biomedical Optics Express CrossRef
7. Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors.
   Rajani Rai et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. Immunological landscape of solid cancer: Interplay between tumor and autoimmunity
   Ajay K. Singh et al, 2024, Targeting Signaling Pathways in Solid Tumors - Part C CrossRef
9. Mesoporous Silica Nanoparticle-Based Combination of Niclosamide and Doxorubicin: Effect of Treatment Regimens on Breast Cancer Subtypes
   Garima Lohiya et al, 2021, ACS Applied Bio Materials CrossRef
10. Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
    Alf Spitschak et al, 2022, Pharmaceutics CrossRef
11. Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
    Sze-Kwan Lam et al, 2022, Frontiers in Pharmacology CrossRef
12. Breast Cancer Drug Repurposing a Tool for a Challenging Disease
    Jonaid Ahmad Malik et al, 2022, Drug Repurposing - Molecular Aspects and Therapeutic Applications CrossRef
13. Niclosamide inhibits epithelial-mesenchymal transition with apoptosis induction in BRAF/ NRAS mutated metastatic melanoma cells
    Sowjanya Thatikonda et al, 2023, Toxicology in Vitro CrossRef
14. Preparation and pharmacodynamics of Niclosamide-hydroxypropyl-β-cyclodextrin inclusion complex
    Lukuan Liu et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
15. Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
    Zhan Wang et al, 2022, International Journal of Molecular Sciences CrossRef
16. Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer
    Shentao Zhang et al, 2022, Journal of Drug Delivery Science and Technology CrossRef